M&A Deal Summary

AMAG Pharmaceuticals Acquires Lumara Health

On September 29, 2014, AMAG Pharmaceuticals acquired life science company Lumara Health for 675M USD

Acquisition Highlights
  • This is AMAG Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is AMAG Pharmaceuticals’ 2nd largest (disclosed) transaction.
  • This is AMAG Pharmaceuticals’ 1st transaction in the United States.
  • This is AMAG Pharmaceuticals’ 1st transaction in Montana.

M&A Deal Summary

Date 2014-09-29
Target Lumara Health
Sector Life Science
Buyer(s) AMAG Pharmaceuticals
Deal Type Add-on Acquisition
Deal Value 675M USD
Advisor(s) Perella Weinberg Partners
T.R. Winston & Co. LLC (Financial)
Dechert (Legal)

Target

Lumara Health

St. Louis, Montana, United States
Lumara Health, Inc. is a pharmaceutical company committed to advancing the health of women throughout the stages of their lives, with a particular focus on maternal health.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

AMAG Pharmaceuticals

Waltham, Massachusetts, United States

Category Company
Founded 1981
Sector Life Science
Employees440
Revenue 328M USD (2019)
DESCRIPTION

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company that markets Feraheme (ferumoxytol) Injection and MuGard® Mucoadhesive Oral Wound Rinse. AMAG Pharmaceuticals was formed in 1981 and is based in Waltham, Massachusetts.


DEAL STATS #
Overall 1 of 3
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 3
State (Montana) 1 of 1
Country (United States) 1 of 3
Year (2014) 1 of 1
Size (of disclosed) 2 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-08-17 Cord Blood Registry

San Bruno, California, United States

CBR Systems is a late-stage medical devices company with the leading market position in providing the collection, processing and cryogenically-frozen storage of stem cells.

Buy $700M